Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 54Lymphoma, Large B-Cell, Diffuse 49Lymphoma, Non-Hodgkin 48Lymphoma, Mantle-Cell 37Lymphoma, Follicular 32Hodgkin Disease 28Lymphoma, Large-Cell, Immunoblastic 23Burkitt Lymphoma 22Leukemia, Lymphocytic, Chronic, B-Cell 21Glioblastoma 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 17Lymphoma, B-Cell, Marginal Zone 15Gliosarcoma 15Brain Neoplasms 15Central Nervous System Neoplasms 14Neoplasms, Plasma Cell 11Glioma 11Astrocytoma 11Leukemia 10Lymphoma, B-Cell 9Recurrence 7Lymphoma, T-Cell 7Waldenstrom Macroglobulinemia 5Oligodendroglioma 5Lymphoma, T-Cell, Peripheral 5Lymphoma, T-Cell, Cutaneous 4Lymphoma, Large-Cell, Anaplastic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Acute 4

Interventions

liposomal doxorubicin 1fialuridine 1Salvia hispanica seed extract 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cytarabine 1Cyclophosphamide 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, Primary Effusion × Carmustine × Clear all
NCT00345865 2020-07-14

Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
473 enrolled 16 charts
Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡